A case of COVID-19 infection presenting with a seizure following severe brain edema.
Identifieur interne : 001405 ( Main/Corpus ); précédent : 001404; suivant : 001406A case of COVID-19 infection presenting with a seizure following severe brain edema.
Auteurs : Yoshinori Kadono ; Yusaku Nakamura ; Yoshihiko Ogawa ; Shota Yamamoto ; Ryuichiro Kajikawa ; Yoshikazu Nakajima ; Masayasu Matsumoto ; Haruhiko KishimaSource :
- Seizure [ 1532-2688 ] ; 2020.
English descriptors
- KwdEn :
- Adult (MeSH), Anti-Bacterial Agents (therapeutic use), Anticoagulants (therapeutic use), Anticonvulsants (therapeutic use), Azithromycin (therapeutic use), Betacoronavirus (MeSH), Brain Edema (diagnostic imaging), Brain Edema (etiology), Brain Infarction (surgery), COVID-19 (MeSH), COVID-19 Testing (MeSH), Clinical Laboratory Techniques (MeSH), Coronavirus Infections (complications), Coronavirus Infections (diagnosis), Coronavirus Infections (drug therapy), Coronavirus Infections (physiopathology), Decompression, Surgical (MeSH), Enzyme Inhibitors (therapeutic use), Epilepsy (complications), Glucocorticoids (therapeutic use), Humans (MeSH), Hydroxychloroquine (therapeutic use), Intracranial Hemorrhages (surgery), Lung (diagnostic imaging), Magnetic Resonance Imaging (MeSH), Male (MeSH), Nephrosis (complications), Nephrosis (drug therapy), Olfaction Disorders (etiology), Pandemics (MeSH), Pneumonia, Viral (complications), Pneumonia, Viral (diagnosis), Pneumonia, Viral (drug therapy), Pneumonia, Viral (physiopathology), Prednisone (therapeutic use), Pregnenediones (therapeutic use), SARS-CoV-2 (MeSH), Seizures (diagnosis), Seizures (drug therapy), Seizures (etiology), Severity of Illness Index (MeSH), Sinus Thrombosis, Intracranial (etiology), Sinus Thrombosis, Intracranial (surgery), Tomography, X-Ray Computed (MeSH).
- MESH :
- chemical , therapeutic use : Anti-Bacterial Agents, Anticoagulants, Anticonvulsants, Azithromycin, Enzyme Inhibitors, Glucocorticoids, Hydroxychloroquine, Prednisone, Pregnenediones.
- complications : Coronavirus Infections, Epilepsy, Nephrosis, Pneumonia, Viral.
- diagnosis : Coronavirus Infections, Pneumonia, Viral, Seizures.
- diagnostic imaging : Brain Edema, Lung.
- drug therapy : Coronavirus Infections, Nephrosis, Pneumonia, Viral, Seizures.
- etiology : Brain Edema, Olfaction Disorders, Seizures, Sinus Thrombosis, Intracranial.
- physiopathology : Coronavirus Infections, Pneumonia, Viral.
- surgery : Brain Infarction, Intracranial Hemorrhages, Sinus Thrombosis, Intracranial.
- Adult, Betacoronavirus, COVID-19, COVID-19 Testing, Clinical Laboratory Techniques, Decompression, Surgical, Humans, Magnetic Resonance Imaging, Male, Pandemics, SARS-CoV-2, Severity of Illness Index, Tomography, X-Ray Computed.
DOI: 10.1016/j.seizure.2020.06.015
PubMed: 32540636
PubMed Central: PMC7282752
Links to Exploration step
pubmed:32540636Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">A case of COVID-19 infection presenting with a seizure following severe brain edema.</title><author><name sortKey="Kadono, Yoshinori" sort="Kadono, Yoshinori" uniqKey="Kadono Y" first="Yoshinori" last="Kadono">Yoshinori Kadono</name><affiliation><nlm:affiliation>Department of Neurosurgery, Osaka University Graduate School of Medicine, Suita, Japan; Department of Neurosurgery, Sakai City Medical Center, Sakai, Japan. Electronic address: y-kadono@nsurg.med.osaka-u.ac.jp.</nlm:affiliation></affiliation></author><author><name sortKey="Nakamura, Yusaku" sort="Nakamura, Yusaku" uniqKey="Nakamura Y" first="Yusaku" last="Nakamura">Yusaku Nakamura</name><affiliation><nlm:affiliation>Department of Neurology, Sakai City Medical Center, Sakai, Japan.</nlm:affiliation></affiliation></author><author><name sortKey="Ogawa, Yoshihiko" sort="Ogawa, Yoshihiko" uniqKey="Ogawa Y" first="Yoshihiko" last="Ogawa">Yoshihiko Ogawa</name><affiliation><nlm:affiliation>Department of Infectious disease, Sakai City Medical Center, Sakai, Japan.</nlm:affiliation></affiliation></author><author><name sortKey="Yamamoto, Shota" sort="Yamamoto, Shota" uniqKey="Yamamoto S" first="Shota" last="Yamamoto">Shota Yamamoto</name><affiliation><nlm:affiliation>Department of Neurosurgery, Osaka University Graduate School of Medicine, Suita, Japan; Department of Neurosurgery, Sakai City Medical Center, Sakai, Japan.</nlm:affiliation></affiliation></author><author><name sortKey="Kajikawa, Ryuichiro" sort="Kajikawa, Ryuichiro" uniqKey="Kajikawa R" first="Ryuichiro" last="Kajikawa">Ryuichiro Kajikawa</name><affiliation><nlm:affiliation>Department of Neurosurgery, Sakai City Medical Center, Sakai, Japan.</nlm:affiliation></affiliation></author><author><name sortKey="Nakajima, Yoshikazu" sort="Nakajima, Yoshikazu" uniqKey="Nakajima Y" first="Yoshikazu" last="Nakajima">Yoshikazu Nakajima</name><affiliation><nlm:affiliation>Department of Neurosurgery, Sakai City Medical Center, Sakai, Japan.</nlm:affiliation></affiliation></author><author><name sortKey="Matsumoto, Masayasu" sort="Matsumoto, Masayasu" uniqKey="Matsumoto M" first="Masayasu" last="Matsumoto">Masayasu Matsumoto</name><affiliation><nlm:affiliation>Department of Neurology, Sakai City Medical Center, Sakai, Japan.</nlm:affiliation></affiliation></author><author><name sortKey="Kishima, Haruhiko" sort="Kishima, Haruhiko" uniqKey="Kishima H" first="Haruhiko" last="Kishima">Haruhiko Kishima</name><affiliation><nlm:affiliation>Department of Neurosurgery, Osaka University Graduate School of Medicine, Suita, Japan.</nlm:affiliation></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2020">2020</date><idno type="RBID">pubmed:32540636</idno><idno type="pmid">32540636</idno><idno type="doi">10.1016/j.seizure.2020.06.015</idno><idno type="pmc">PMC7282752</idno><idno type="wicri:Area/Main/Corpus">001405</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">001405</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">A case of COVID-19 infection presenting with a seizure following severe brain edema.</title><author><name sortKey="Kadono, Yoshinori" sort="Kadono, Yoshinori" uniqKey="Kadono Y" first="Yoshinori" last="Kadono">Yoshinori Kadono</name><affiliation><nlm:affiliation>Department of Neurosurgery, Osaka University Graduate School of Medicine, Suita, Japan; Department of Neurosurgery, Sakai City Medical Center, Sakai, Japan. Electronic address: y-kadono@nsurg.med.osaka-u.ac.jp.</nlm:affiliation></affiliation></author><author><name sortKey="Nakamura, Yusaku" sort="Nakamura, Yusaku" uniqKey="Nakamura Y" first="Yusaku" last="Nakamura">Yusaku Nakamura</name><affiliation><nlm:affiliation>Department of Neurology, Sakai City Medical Center, Sakai, Japan.</nlm:affiliation></affiliation></author><author><name sortKey="Ogawa, Yoshihiko" sort="Ogawa, Yoshihiko" uniqKey="Ogawa Y" first="Yoshihiko" last="Ogawa">Yoshihiko Ogawa</name><affiliation><nlm:affiliation>Department of Infectious disease, Sakai City Medical Center, Sakai, Japan.</nlm:affiliation></affiliation></author><author><name sortKey="Yamamoto, Shota" sort="Yamamoto, Shota" uniqKey="Yamamoto S" first="Shota" last="Yamamoto">Shota Yamamoto</name><affiliation><nlm:affiliation>Department of Neurosurgery, Osaka University Graduate School of Medicine, Suita, Japan; Department of Neurosurgery, Sakai City Medical Center, Sakai, Japan.</nlm:affiliation></affiliation></author><author><name sortKey="Kajikawa, Ryuichiro" sort="Kajikawa, Ryuichiro" uniqKey="Kajikawa R" first="Ryuichiro" last="Kajikawa">Ryuichiro Kajikawa</name><affiliation><nlm:affiliation>Department of Neurosurgery, Sakai City Medical Center, Sakai, Japan.</nlm:affiliation></affiliation></author><author><name sortKey="Nakajima, Yoshikazu" sort="Nakajima, Yoshikazu" uniqKey="Nakajima Y" first="Yoshikazu" last="Nakajima">Yoshikazu Nakajima</name><affiliation><nlm:affiliation>Department of Neurosurgery, Sakai City Medical Center, Sakai, Japan.</nlm:affiliation></affiliation></author><author><name sortKey="Matsumoto, Masayasu" sort="Matsumoto, Masayasu" uniqKey="Matsumoto M" first="Masayasu" last="Matsumoto">Masayasu Matsumoto</name><affiliation><nlm:affiliation>Department of Neurology, Sakai City Medical Center, Sakai, Japan.</nlm:affiliation></affiliation></author><author><name sortKey="Kishima, Haruhiko" sort="Kishima, Haruhiko" uniqKey="Kishima H" first="Haruhiko" last="Kishima">Haruhiko Kishima</name><affiliation><nlm:affiliation>Department of Neurosurgery, Osaka University Graduate School of Medicine, Suita, Japan.</nlm:affiliation></affiliation></author></analytic><series><title level="j">Seizure</title><idno type="eISSN">1532-2688</idno><imprint><date when="2020" type="published">2020</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adult (MeSH)</term><term>Anti-Bacterial Agents (therapeutic use)</term><term>Anticoagulants (therapeutic use)</term><term>Anticonvulsants (therapeutic use)</term><term>Azithromycin (therapeutic use)</term><term>Betacoronavirus (MeSH)</term><term>Brain Edema (diagnostic imaging)</term><term>Brain Edema (etiology)</term><term>Brain Infarction (surgery)</term><term>COVID-19 (MeSH)</term><term>COVID-19 Testing (MeSH)</term><term>Clinical Laboratory Techniques (MeSH)</term><term>Coronavirus Infections (complications)</term><term>Coronavirus Infections (diagnosis)</term><term>Coronavirus Infections (drug therapy)</term><term>Coronavirus Infections (physiopathology)</term><term>Decompression, Surgical (MeSH)</term><term>Enzyme Inhibitors (therapeutic use)</term><term>Epilepsy (complications)</term><term>Glucocorticoids (therapeutic use)</term><term>Humans (MeSH)</term><term>Hydroxychloroquine (therapeutic use)</term><term>Intracranial Hemorrhages (surgery)</term><term>Lung (diagnostic imaging)</term><term>Magnetic Resonance Imaging (MeSH)</term><term>Male (MeSH)</term><term>Nephrosis (complications)</term><term>Nephrosis (drug therapy)</term><term>Olfaction Disorders (etiology)</term><term>Pandemics (MeSH)</term><term>Pneumonia, Viral (complications)</term><term>Pneumonia, Viral (diagnosis)</term><term>Pneumonia, Viral (drug therapy)</term><term>Pneumonia, Viral (physiopathology)</term><term>Prednisone (therapeutic use)</term><term>Pregnenediones (therapeutic use)</term><term>SARS-CoV-2 (MeSH)</term><term>Seizures (diagnosis)</term><term>Seizures (drug therapy)</term><term>Seizures (etiology)</term><term>Severity of Illness Index (MeSH)</term><term>Sinus Thrombosis, Intracranial (etiology)</term><term>Sinus Thrombosis, Intracranial (surgery)</term><term>Tomography, X-Ray Computed (MeSH)</term></keywords><keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Anti-Bacterial Agents</term><term>Anticoagulants</term><term>Anticonvulsants</term><term>Azithromycin</term><term>Enzyme Inhibitors</term><term>Glucocorticoids</term><term>Hydroxychloroquine</term><term>Prednisone</term><term>Pregnenediones</term></keywords><keywords scheme="MESH" qualifier="complications" xml:lang="en"><term>Coronavirus Infections</term><term>Epilepsy</term><term>Nephrosis</term><term>Pneumonia, Viral</term></keywords><keywords scheme="MESH" qualifier="diagnosis" xml:lang="en"><term>Coronavirus Infections</term><term>Pneumonia, Viral</term><term>Seizures</term></keywords><keywords scheme="MESH" qualifier="diagnostic imaging" xml:lang="en"><term>Brain Edema</term><term>Lung</term></keywords><keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Coronavirus Infections</term><term>Nephrosis</term><term>Pneumonia, Viral</term><term>Seizures</term></keywords><keywords scheme="MESH" qualifier="etiology" xml:lang="en"><term>Brain Edema</term><term>Olfaction Disorders</term><term>Seizures</term><term>Sinus Thrombosis, Intracranial</term></keywords><keywords scheme="MESH" qualifier="physiopathology" xml:lang="en"><term>Coronavirus Infections</term><term>Pneumonia, Viral</term></keywords><keywords scheme="MESH" qualifier="surgery" xml:lang="en"><term>Brain Infarction</term><term>Intracranial Hemorrhages</term><term>Sinus Thrombosis, Intracranial</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Adult</term><term>Betacoronavirus</term><term>COVID-19</term><term>COVID-19 Testing</term><term>Clinical Laboratory Techniques</term><term>Decompression, Surgical</term><term>Humans</term><term>Magnetic Resonance Imaging</term><term>Male</term><term>Pandemics</term><term>SARS-CoV-2</term><term>Severity of Illness Index</term><term>Tomography, X-Ray Computed</term></keywords></textClass></profileDesc></teiHeader></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">32540636</PMID><DateCompleted><Year>2020</Year><Month>08</Month><Day>27</Day></DateCompleted><DateRevised><Year>2021</Year><Month>01</Month><Day>10</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1532-2688</ISSN><JournalIssue CitedMedium="Internet"><Volume>80</Volume><PubDate><Year>2020</Year><Month>08</Month></PubDate></JournalIssue><Title>Seizure</Title><ISOAbbreviation>Seizure</ISOAbbreviation></Journal><ArticleTitle>A case of COVID-19 infection presenting with a seizure following severe brain edema.</ArticleTitle><Pagination><MedlinePgn>53-55</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">S1059-1311(20)30180-1</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.seizure.2020.06.015</ELocationID><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kadono</LastName><ForeName>Yoshinori</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Neurosurgery, Osaka University Graduate School of Medicine, Suita, Japan; Department of Neurosurgery, Sakai City Medical Center, Sakai, Japan. Electronic address: y-kadono@nsurg.med.osaka-u.ac.jp.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nakamura</LastName><ForeName>Yusaku</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Neurology, Sakai City Medical Center, Sakai, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ogawa</LastName><ForeName>Yoshihiko</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Infectious disease, Sakai City Medical Center, Sakai, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yamamoto</LastName><ForeName>Shota</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Neurosurgery, Osaka University Graduate School of Medicine, Suita, Japan; Department of Neurosurgery, Sakai City Medical Center, Sakai, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kajikawa</LastName><ForeName>Ryuichiro</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Neurosurgery, Sakai City Medical Center, Sakai, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nakajima</LastName><ForeName>Yoshikazu</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Neurosurgery, Sakai City Medical Center, Sakai, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Matsumoto</LastName><ForeName>Masayasu</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Neurology, Sakai City Medical Center, Sakai, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kishima</LastName><ForeName>Haruhiko</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Neurosurgery, Osaka University Graduate School of Medicine, Suita, Japan.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D002363">Case Reports</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>06</Month><Day>09</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Seizure</MedlineTA><NlmUniqueID>9306979</NlmUniqueID><ISSNLinking>1059-1311</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000900">Anti-Bacterial Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000925">Anticoagulants</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000927">Anticonvulsants</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D004791">Enzyme Inhibitors</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D005938">Glucocorticoids</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011282">Pregnenediones</NameOfSubstance></Chemical><Chemical><RegistryNumber>4QWG6N8QKH</RegistryNumber><NameOfSubstance UI="D006886">Hydroxychloroquine</NameOfSubstance></Chemical><Chemical><RegistryNumber>83905-01-5</RegistryNumber><NameOfSubstance UI="D017963">Azithromycin</NameOfSubstance></Chemical><Chemical><RegistryNumber>S59502J185</RegistryNumber><NameOfSubstance UI="C120481">ciclesonide</NameOfSubstance></Chemical><Chemical><RegistryNumber>VB0R961HZT</RegistryNumber><NameOfSubstance UI="D011241">Prednisone</NameOfSubstance></Chemical></ChemicalList><SupplMeshList><SupplMeshName Type="Protocol" UI="C000705127">COVID-19 drug treatment</SupplMeshName></SupplMeshList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000900" MajorTopicYN="N">Anti-Bacterial Agents</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000925" MajorTopicYN="N">Anticoagulants</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000927" MajorTopicYN="N">Anticonvulsants</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017963" MajorTopicYN="N">Azithromycin</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000073640" MajorTopicYN="N">Betacoronavirus</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001929" MajorTopicYN="N">Brain Edema</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="Y">diagnostic imaging</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020520" MajorTopicYN="N">Brain Infarction</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="N">COVID-19</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086742" MajorTopicYN="N">COVID-19 Testing</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019411" MajorTopicYN="N">Clinical Laboratory Techniques</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018352" MajorTopicYN="N">Coronavirus Infections</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019299" MajorTopicYN="N">Decompression, Surgical</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004791" MajorTopicYN="N">Enzyme Inhibitors</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004827" MajorTopicYN="N">Epilepsy</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005938" MajorTopicYN="N">Glucocorticoids</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006886" MajorTopicYN="N">Hydroxychloroquine</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020300" MajorTopicYN="N">Intracranial Hemorrhages</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008168" MajorTopicYN="N">Lung</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="Y">diagnostic imaging</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008279" MajorTopicYN="N">Magnetic Resonance Imaging</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009401" MajorTopicYN="N">Nephrosis</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000857" MajorTopicYN="N">Olfaction Disorders</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011024" MajorTopicYN="N">Pneumonia, Viral</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011241" MajorTopicYN="N">Prednisone</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011282" MajorTopicYN="N">Pregnenediones</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012640" MajorTopicYN="N">Seizures</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012720" MajorTopicYN="N">Severity of Illness Index</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012851" MajorTopicYN="N">Sinus Thrombosis, Intracranial</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014057" MajorTopicYN="N">Tomography, X-Ray Computed</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="Y">Brain edema</Keyword><Keyword MajorTopicYN="Y">COVID–19</Keyword><Keyword MajorTopicYN="Y">Cerebral venous thrombosis</Keyword><Keyword MajorTopicYN="Y">Coronavirus</Keyword><Keyword MajorTopicYN="Y">Focal seizure</Keyword></KeywordList><CoiStatement>Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>06</Month><Day>05</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>06</Month><Day>06</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>6</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>8</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>6</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32540636</ArticleId><ArticleId IdType="pii">S1059-1311(20)30180-1</ArticleId><ArticleId IdType="doi">10.1016/j.seizure.2020.06.015</ArticleId><ArticleId IdType="pmc">PMC7282752</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>J Med Virol. 2020 Jun;92(6):552-555</Citation><ArticleIdList><ArticleId IdType="pubmed">32104915</ArticleId></ArticleIdList></Reference><Reference><Citation>J Am Coll Cardiol. 2020 Jun 16;75(23):2950-2973</Citation><ArticleIdList><ArticleId IdType="pubmed">32311448</ArticleId></ArticleIdList></Reference><Reference><Citation>Int Forum Allergy Rhinol. 2020 Sep;10(9):1103-1104</Citation><ArticleIdList><ArticleId IdType="pubmed">32342636</ArticleId></ArticleIdList></Reference><Reference><Citation>Seizure. 2020 May;78:109-112</Citation><ArticleIdList><ArticleId IdType="pubmed">32344366</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></pubmed></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidChloroV1/Data/Main/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001405 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Corpus/biblio.hfd -nk 001405 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= CovidChloroV1
|flux= Main
|étape= Corpus
|type= RBID
|clé= pubmed:32540636
|texte= A case of COVID-19 infection presenting with a seizure following severe brain edema.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Corpus/RBID.i -Sk "pubmed:32540636" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Corpus/biblio.hfd \
| NlmPubMed2Wicri -a CovidChloroV1
| This area was generated with Dilib version V0.6.38. |  |